Overview
It depends on which regimen you are on, and the two work quite differently.
A sequential (cyclical) regimen gives estrogen continuously and the progestogen for part of each month. It produces a predictable monthly bleed, and that is the intended behavior. It is generally used in perimenopause and early after the final period.
A continuous combined regimen gives both hormones every day and is designed to produce no bleeding at all. It is generally used once you are more than about a year past your final period.
| Sequential (cyclical) | Continuous combined | |
|---|---|---|
| Who it is usually for | Perimenopause; within ~12 months of the final period | More than ~12 months past the final period |
| Bleeding by design | Yes — a predictable monthly bleed | No — the goal is none |
| Early irregular bleeding | Some, while it settles | Common in the first 3–6 months |
| After 6 months | Bleeding should be predictable in timing | Bleeding should have stopped |
| When to get it checked | Bleeding that changes pattern, is heavy, or happens between bleeds | Any bleeding after 6 months, or bleeding that restarts |
The line that matters most on this page: unscheduled bleeding in the first three to six months of a new regimen is common and usually settles. Bleeding that starts after it had stopped, or that continues past six months, is not something to wait out. It is usually benign — but it is investigated rather than assumed, because it is also how endometrial cancer presents.
Why the two regimens exist
The progestogen is there to protect the endometrium from unopposed estrogen stimulation. There are two ways to deliver that protection, and they produce different bleeding patterns.
Sequential mimics the natural cycle: estrogen throughout, progestogen for part of the month, then a withdrawal bleed when the progestogen stops. It suits perimenopause, when the ovaries are still producing hormones unpredictably and a continuous regimen tends to produce erratic bleeding.
Continuous combined delivers both daily, which keeps the endometrium thin and inactive. Once established, there is no lining to shed. This is generally the preferred option further from menopause, partly because it avoids monthly bleeding and partly because the continuously suppressed endometrium is what most women want at that stage.
Switching from sequential to continuous is a normal progression rather than a change of plan, and it is a clinical decision about timing.
What is expected early
On a continuous regimen, unscheduled bleeding or spotting in the first three to six months is common. The endometrium takes time to become consistently thin, and while it does, breakthrough bleeding happens. It is expected, it is not a sign the treatment is wrong, and it usually settles.
On a sequential regimen, the timing of the bleed can be irregular in the first few months before it becomes predictable.
Neither of these is a reason to stop, though both are worth mentioning at a review — partly because a persistent pattern sometimes means a regimen adjustment, and partly so that it is on record from the start.
What always needs checking
This is the section that matters, and it is short and specific.
Any bleeding after 12 months without a period, if you are not on hormone therapy, needs investigating. That is the standard definition of postmenopausal bleeding.
On a continuous combined regimen:
- Bleeding that continues beyond six months of starting
- Bleeding that starts again after it had stopped
- Bleeding that is heavy
On a sequential regimen:
- Bleeding between the expected bleeds
- Bleeding that becomes heavier or longer than it was
- Bleeding that continues past the expected window
In all cases: bleeding after sex, or bleeding with pelvic pain.
The reason for the specificity is that most of these turn out to be benign — a polyp, an adjustment, endometrial atrophy, sometimes just absorption. But abnormal bleeding is the main presenting symptom of endometrial cancer, and it is highly treatable when found early. Investigation is usually straightforward — an ultrasound to measure the endometrial thickness, sometimes a biopsy — and it is done to settle the question rather than because something is suspected.
Waiting is the only genuinely bad option here.
Other things that cause bleeding on hormone therapy
Worth knowing, because they are common and they are not all about the treatment.
Missed or late doses, particularly with patches that come off or gel that gets skipped, which produce a drop in levels and a small withdrawal bleed.
Absorption variation, which is one reason route matters. More on that.
Interacting medications, including some antibiotics, antiepileptics and St John's wort, which affect estrogen metabolism.
Polyps and fibroids, which are common in this age group and can bleed independent of the regimen.
Inadequate endometrial protection, which is the specific concern with progestogen forms that have not been shown to protect reliably. Why that matters.
None of these change the rule above — they are explanations that emerge from investigation, not reasons to skip it.
Frequently asked questions
Do you still get periods on HRT? On a sequential regimen, yes — a predictable monthly bleed is the intended pattern. On a continuous combined regimen, no bleeding is the goal once it has settled.
Is spotting normal when I start? On a continuous regimen it is common in the first three to six months. It usually settles. Worth mentioning at your review, not worth stopping over.
When should bleeding be investigated? Bleeding continuing past six months on a continuous regimen, bleeding that restarts after stopping, heavy bleeding, bleeding between expected bleeds on a sequential regimen, or any bleeding after sex.
Does bleeding mean the dose is wrong? Sometimes, and it is one of several explanations — a dose missed or taken late, absorption, polyps and interacting medications are others. Which it is comes from assessment rather than from adjusting on your own.
Will I know when I have actually gone through menopause? Not from bleeding pattern while on treatment, since the bleeding is the regimen rather than your own cycle. It is worked out from your age and history rather than from a test.
Where this fits in your plan
Bleeding on hormone therapy is common, usually explainable and occasionally important — and the difference is not something to judge from an article.
The workable approach is knowing which pattern your regimen is meant to produce, and treating any departure from it as a question to ask rather than a thing to monitor. What hormone therapy with us involves.
We measure first. Then we act.
Ready to start your second act?
It starts with measuring, not guessing. A short, clinician-reviewed assessment shows what fits you.
This article is educational and is not medical advice. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. Individual results vary.
